SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 3.79 |
Enterprise Value ($M) | 33.03 |
Book Value ($M) | 8.98 |
Book Value / Share | 13.32 |
Price / Book | 0.42 |
NCAV ($M) | -12.25 |
NCAV / Share | -18.17 |
Price / NCAV | -0.31 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.85 |
Return on Assets (ROA) | -0.69 |
Return on Equity (ROE) | -2.69 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 1.11 |
Current Ratio | 1.63 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 32.20 |
Assets | 53.42 |
Liabilities | 44.45 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 11.69 |
Operating Income | -30.83 |
Net Income | -38.49 |
Earnings Per Share Basic And Diluted | n/a |
Earnings Per Share Diluted | n/a |
Earnings Per Share Basic | n/a |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | -29.38 |
Cash from Investing | -0.23 |
Cash from Financing | 31.20 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G | Uptown Capital, LLC | 9.90 | ||
13G/A | Iliad Research & Trading, L.P. | 9.13 | 102.12 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
1,970 | 9,768 | 20.17 | |
47,944 | 171,245 | 28.00 | |
13,829 | 35,750 | 38.68 | |
30,465 | 142,218 | 21.42 | |
(click for more detail) |
Similar Companies | |
---|---|
IPA – ImmunoPrecise Antibodies Ltd. | IRD – Opus Genetics, Inc. |
ITRM – Iterum Therapeutics plc | JSPR – Jasper Therapeutics, Inc. |
KALA – KALA BIO, Inc. |
Financial data and stock pages provided by
Fintel.io